Recent research suggests that exposure to organochlorines, such as dieldrin
that possess estrogenic properties, may increase the risk of breast cancer
by promoting growth of malignant cells. Whether this potential also affect
s malignant cells not eradicated by treatment, and thereby survival, is unk
nown. To evaluate this blood samples from female participants in the Copenh
agen City Heart Study, Denmark, were analyzed for organochlorines. A total
of 195 breast cancer cases, who each provided two blood samples that were t
aken in 1976-78 and 1981-83, respectively, were included in the survival an
alysis. Dieldrin had a significant adverse effect on overall survival and b
reast cancer specific survival (RR, 2.78, 95% CI, 1.38-5.59, P trend < 0.01
; RR, 2.61, 95% CI, 0.97-7.01, P trend < 0.01). This association was streng
thened when exposure was assessed as the average serum concentration of the
two measurements. These findings suggest that past exposure to estrogenic
organochlorines such as dieldrin may not only affect the risk of developing
breast cancer but also the survival. (C) 2000 Elsevier Science Inc. All ri
ghts reserved.